Mirum Pharmaceuticals

MIRM · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

NOV

4

Q3 2025

Reported

Reported earnings 3 months ago

Total Revenue

$133M

Previous year: $90.4M

Total Operating Expenses

Loading...

Mirum Pharmaceuticals

Unlock previous datapoints

Upgrade

Mirum Pharmaceuticals

Unlock previous datapoints

Upgrade

Mirum Pharmaceuticals Revenue by Segment

Revenue by Segment

Product sales, net Revenue

CapyFin.com

LIVMARLI net product sales Revenue

CapyFin.com

Bile Acid Medicines net product sales Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$5.33B

P/E Ratio

-46.98

Sector

N/A

Industry

N/A

52-Week High

$105

52-Week Low

$38.3

R&D Expenses

$43M

SG&A Expenses

$61.9M

Total Operating Expenses

$130M

Interest Income

$3.25M

Interest Expense

$3.61M

Products

Get in Touch

Resources

Mirum Pharmaceuticals

Mirum Pharmaceuticals

Mirum Pharmaceuticals

Mirum Pharmaceuticals Revenue by Segment

Revenue by Segment

Product sales, net Revenue

LIVMARLI net product sales Revenue

Bile Acid Medicines net product sales Revenue

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics